All posts by imreal

Man in Christian Existence Working Obediently Regarding Lord’s Direction” is a unique and entertaining fiction


News Image

“MICE-WORLD: Man in Christian Existence Working Obediently Regarding Lord’s Direction”: a delightful and creative short story. “MICE-WORLD: Man in Christian Existence Working Obediently Regarding Lord’s Direction” is the creation of published author D. L. Emerich, who was born in Wisconsin and raised in California. He became a minister in 2005 after graduating from Cottonwood School of Ministry.

Emerich shares, “Tail 1 follows MICE-Driver on a quest to reap the wisdom of his fellow Mousepotamians in the skill of driving to share their wisdom with the students in his driver’s education class. What follows is an adventure story both refreshingly unique and entertaining. Driver meets up with several fun characters and even encounters the evil pitchfork gang. This is the first of many Tails to be told, and if you listen, you may even hear the Lord Jesus Christ, God of all creation. Reading along with you. Enjoy and God bless.”

Published by Christian Faith Publishing, D. L. Emerich’s new book is the first installment to the author’s intended “MICE-WORLD” series.

Emerich’s creatively inspiring storytelling will draw readers in from the start as a unique community filled with affable characters and important lessons of faith unfolds.

Consumers can purchase “MICE-WORLD: Man in Christian Existence Working Obediently Regarding Lord’s Direction” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “MICE-WORLD: Man in Christian Existence Working Obediently Regarding Lord’s Direction,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

‘Mindful in 5’ can help busy Americans address anxiety epidemic


News Image

Spiwe Jefferson, CMP, JD, had a revelation while writing “Mindful in 5,” her first in the book series. Millions of adult Americans are stressed. Anxiety-based disorders are now the most common mental health concern in the United States.* What if there was a way to help busy, anxious professionals reduce stress, unlock their inner strength, and overcome the challenges of daily life with deeper calm and equanimity?

“We have collectively experienced unprecedented stressors, including the global pandemic, war, and worsening climate conditions. In the explosion of fear, stress, and loneliness, many people are searching for healthy, cost-effective solutions that will help them survive and thrive in a complex, interconnected world,” Jefferson says.

Relatable, captivating characters, insightful stories, and journal reflections guide those desiring a better life to be consistently present and realize inner peace even during challenging times, starting with just five minutes a day.

In her own quest to attain the benefits of mindfulness, most books that Jefferson found offered an abstract exploration of the subject. She wrote “Mindful in 5: Meditations for People with No Time” (published by Archway Publishing) as an example-based, step-by-step roadmap that empowers readers to translate mindfulness meditation concepts into action that will help them reduce stress, build optimism, and improve overall well-being.

Based on scientifically proven techniques,** “Mindful in 5” utilizes three distinct “seasons” — Dawn, Day, and Dark — that meet readers where they are. They can progress by deep reflection, emerging into reframed perspectives.

When asked what she wants readers to take away from the book, Jefferson said, “Mindfulness meditation won’t solve your problems. But with consistent practice, anyone can master it to improve their general outlook and overall quality of life. Set your intention to live and work to your highest and best purpose, starting with just five minutes a day.” For more details about the book, please visit https://www.archwaypublishing.com/en/bookstore/bookdetails/836681-mindful-in-5

*https://www.nami.org/About-Mental-Illness/Mental-Health-Conditions/Anxiety-Disorders

**Jefferson draws from myriad research and scientific studies to compile the mindfulness meditation guidance in this book.

“Mindful in 5: Meditations for People with No Time”

By Spiwe Jefferson, CMP, JD

Hardcover | 6 x 9in | 236 pages | ISBN 9781665720526

Softcover | 6 x 9in | 236 pages | ISBN 9781665720540

E-Book | 236 pages | ISBN 9781665720533

Available at Amazon and Barnes & Noble

About the Author

Spiwe Jefferson, CMP, JD is an attorney, certified mindfulness practitioner, and long-time student of mindfulness meditation. In 2008, he suffered a tragedy that launched her own wilderness journey and prompted many of the life lessons that brought her triumphs. “Mindful in 5” is the first book in an intended series. Companion journal coming soon.

Simon & Schuster, a company with nearly ninety years of publishing experience, has teamed up with Author Solutions, LLC, the worldwide leader in self-publishing, to create Archway Publishing. With unique resources to support books of all kind, Archway Publishing offers a specialized approach to help every author reach his or her desired audience. For more information, visit archwaypublishing.com or call 844-669-3957.

Share article on social media or email:

Marcie Nataly’s newly released “Middlesex Triplet” is an encouraging arrangement of personal poetry inspired by the author’s faith


News Image

“Middlesex Triplet”: an inspiring message of God’s love despite life’s challenges. “Middlesex Triplet” is the creation of published author Marcie Nataly.

Nataly shares, “Marcia is a triplet, and the three of them, her identical triplet sister, Marla, and fraternal triplet brother Mark, were born in Concord, MA. Her love for God and family drew her to write poetry since the early eighties. A compassion for helping others believe in and know God not just of him but also in heart and soul led her to write and pursue writing. The poetry reflects times of new hope and encouragement in the midst of trials and tribulations. These circumstances gave her a keen awareness that God is with you and realize underneath you are his strong, loving, everlasting arms. We only have to receive him.

“Lindquist-Nataly became a nurse out of high school, then returned to college while teaching and subsequently working for pro-family positions. Enrolling at Liberty University, Lynchburg, VA, home study college courses, she completed most of the course work and then took on a doctor’s office nurse position. From there, she met her husband and found light, life, and love in a marriage made in heaven. Their son, Jacob, came along as a miracle baby, bringing Marcie and Fritz the dreams they had always hoped for.

“Whether you’re a teen, an adult, or senior, single, divorced, or challenged mentally or physically, you will find peace, hope, and freedom to love and forgive. God gave each of us a gift—the gift of life. Never give up. Be strong and courageous never be afraid or discouraged, for the Lord your God is with you wherever you go (Joshua 1:9).”

Published by Christian Faith Publishing, Marcie Nataly’s new book provides readers a message of encouragement that is certain to resonate with many.

Nataly expresses a heartfelt appreciation and awareness of God within the pages of this thought-provoking work.

Consumers can purchase “Middlesex Triplet” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Middlesex Triplet,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Kenn and Wendy Ferrell’s newly released “Hand in Hand” is an exciting resource for married couples seeking to strengthen their marital connection


News Image

“Hand in Hand”: an encouraging message regarding the promise that marriage holds. “Hand in Hand” is the creation of published authors Kenn and Wendy Ferrell.

The Ferrells share, “The Bible asks the question, ‘Can two people walk together without agreeing on the direction?’ (Amos 3:3 NLT). The answer is obvious to everyone. Hand in Hand was written to help every couple discuss the direction of their marriage while holding hands with no intention of letting go. Wedding vows are every couple’s proof that they have agreed to walk side by side. But what is the next direction in your journey? The answer isn’t as obvious as Amos’s thought. The explanation is as unique as your relationship, but effective communication smoothens the potholes in the road. Smiles, laughter, tears, and intimacy all await you on this journey. Embrace each change of direction or twist in the trail as long as you are walking hand in hand.

“Hand in Hand is a once-a-week devotion encompassing a full year. Each one is designed to be read together. Each devotion is composed of four segments that were created to enhance intimate conversations. The first segment articulates colorful analogies that reveal life application. The second segment is called ‘Pillow Talk.’ Four questions are concealed here and are intended to activate heart-to-heart conversations. ‘Prayer Focus’ will follow, intertwining the devotion, your marriage, and His Word, which activates spiritual growth. The last segment is called ‘Walking It Out.’ Each week you will have an opportunity to express your love through action. This is designed to incorporate a fun or romantic expression of the collaborated understanding that you have received from that week’s corresponding devotion. So lace up your brand-new hiking boots, take each other’s hand, and enjoy the adventure of your lifelong journey together!”

Published by Christian Faith Publishing, Kenn and Wendy Ferrell’s new book will inspire and encourage as readers work through each devotion together.

The Ferrells share in hopes of helping others to establish committed, successful marriages that will last a lifetime.

Consumers can purchase “Hand in Hand” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Hand in Hand,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Mediaplanet and Osteoarthritis Action Alliance Team Up in the Bones & Joints Campaign


Mediaplanet announces the launch of its June edition of “Bones & Joints” magazine. This campaign addresses key bone and joint issues that Americans might face such as Osteoarthritis, Lupus, Scoliosis and more. It acts as a resource for the best treatment options and resources available now.

Osteoarthritis Action Alliance touches on how although there is no cure for osteoarthritis, joint pain and symptoms can be managed through treatment, lifestyle changes, and education.     There are certain low-impact activities that can help build strength over time. Some of these activities include water aerobics, yoga, and walking.

The print component of “Bones & Joints” is distributed within USA Today in New York, Los Angeles, Chicago, Dallas, Houston, San Francisco, Washington DC/Baltimore, Philadelphia, Florida, with a circulation of approximately 150,000 copies and an estimated readership of 450,000. The digital component is distributed nationally, through a vast social media strategy, and across a network of top news sites and partner outlets. To explore the digital version of the campaign, visit: https://www.futureofpersonalhealth.com/

Not many readers might know that although there are more than 100 types of arthritis, osteoarthritis (OA) is the most common form, affecting 32.5 million U.S. adults. To learn more, visit oaaction.unc.edu/JOINTPAIN to learn about treatment and lifestyle changes.

About Mediaplanet

Mediaplanet specializes in the creation of content marketing campaigns covering a variety of industries. We tell meaningful stories that educate our audience and position our clients as solution providers. Our unique ability to pair the right leaders with the right readers, through the right platforms, has made Mediaplanet a global content marketing powerhouse. Our award-winning stories have won the hearts of countless readers while serving as a valuable platform for brands and their missions. Just call us storytellers with a purpose. Please visit http://www.mediaplanet.com for more on who we are and what we do.

Press Contact:

Katie Konfino

Kathleen.konfino@mediaplanet.com

Share article on social media or email:

Want to Lower Financial Stress Levels? Here Are 6 Tips From USECU


“When you have the world weighing on you, taking the time to care for yourself can seem like an impossible luxury, but keeping calm and being as objective as possible can pay off when it comes to your financial future,” said Margarita Guerra, Senior Vice President and CFO at USE Credit Union.

Losing sleep over money or feeling a sense of panic when opening a bill is all too common, and USE Credit Union wants to help. Shifting one’s outlook to a more mindful approach on money can relieve stress and lead to a healthier relationship with family finances.

“When you have the world weighing on you, taking the time to care for yourself can seem like an impossible luxury,” said Margarita Guerra, Senior Vice President and CFO at USE Credit Union. “But keeping calm and being as objective as possible can pay off when it comes to your financial future.”

What Is Mindfulness, Anyway?

Mindfulness is a big topic these days, and mindfulness practices have found their way into many areas of life, from eating to working. In the context of financial well-being, let’s think of mindfulness as a moment-by-moment awareness of our thoughts, feelings and circumstances—with an attitude that is nurturing, not judgmental.

This concept applies to your finances by shifting your mindset. The goal is to bring greater clarity to one’s financial decision-making and reduce stress and anxiety over money. Here’s what to do:

1. Stay Aware

When life gets busy, it’s easy to lose track of finances. Surprise expenses (or a surprisingly low account balance) can turn a little confusion into a lot of stress. Be aware of spending habits — where, why and how much — money is being spent. Using a budget is often key. USECU’s online money management tools were designed to help.

The goal of budgeting is to align money with priorities. It can shed light into what expenses to avoid, like some subscription services or a daily coffee run.

For an eye-opening reality check, try the “no-spend challenge.” Avoid spending money on non-necessities for a specific time frame, like a day or a week. Not only will this save more money, but it will illuminate what expenses really matter when it comes to one’s goals and happiness.

2. Practice Acceptance

For many, self-worth is connected to a feeling of financial success. If it seems like a member of one’s social circle earns more money and lives in a bigger house, it’s easy to feel pressured to “catch up” with peers. But financial well-being isn’t a competition, and everybody’s life is different.

Try to look at finances without judgment. We’re all human, and financial mistakes happen. If big-picture goals are still in the distance, being able to acknowledge that today’s needs are met can help build satisfaction and resilience moving forward.

Don’t forget to acknowledge successes, no matter how small.

3. Find Balance

Through mindful budgeting, strive to create a healthy balance between wants and needs. If one has to work multiple jobs or is struggling to manage high housing costs or student loan payments, this can feel difficult—but it isn’t impossible.

Be clear-eyed about what is and isn’t a necessity while acknowledging that feelings are real and the desire to buy or do fun things is valid, even if postponing these activities or purchases is necessary.

Understanding the motivation behind a purchase helps you tell whether it’s worthwhile. For instance, many people choose to spend money on experiences rather than material possessions, feeling that their memories of a great trip or concert are worth more than stuff.

4. Set Intentions

Are financial decisions made purposefully, or out of habit? Practicing mindful finance can help to set clear goals, as long as you follow them up with action.

For instance, unforeseen expenses are causes for concern — commit to building an emergency savings fund. Identify meaningful steps to take, such as “paying yourself first” by putting money in savings every payday. Remember that it’s okay to start small simply starting to save is a big confidence booster.

Being intentional can also mean making financial choices that reflect values. For example, many people are careful to support companies that have an ethical business model, or they may shop at local businesses and bank at their local credit union because these organizations invest in their community and support causes they believe in.

5. Simplify

When there are a lot of responsibilities, time can feel even more scarce than money. One of the best ways to reduce financial stress is to simplify money management. Here are a few ways to save time:

  • Use online and mobile banking to handle many banking needs.
  • Switch from paper account statements to e-statements (this also helps you cut down on clutter!).
  • Get paid by direct deposit instead of paper paychecks.

6. Pick Up a Meditation Practice

Feeling present in the moment and putting life’s stresses on pause can be powerful. Adopting a meditation practice has helped many people become calmer and more focused. Examples include daily journaling, beginning each day by sitting in silence for a few minutes and practicing mindful breathing, or doing a walking meditation.

There are plenty of practices out there for different personalities, so try some out and see what helps you reach financial peace of mind. The only thing to lose is stress.

“Life doesn’t stop or slow down during fraught financial times,” said Guerra. “The first step in weathering current and future storms is to keep a level head and objectively look at your situation.”

About USE Credit Union

Founded in 1936, University & State Employees Credit Union (USECU) empowers nearly 60,000 members to achieve financial wellness through a full range of financial products and services, including checking and savings options, credit cards, loans, mortgages and more. USECU now has more than $1.3 billion in assets and offers accessibility to its members through eight branches in California, nearly 30,000 surcharge-free ATMs across the nation and 24/7 online and mobile Banking access.

USECU membership is open to all California university employees and students as well as California state employees, along with others who live, work or worship in Alameda County, Sacramento County, San Diego County, Santa Clara County and Yolo County. As a not-for-profit community leader, USECU partners with causes, events and organizations that reflect a commitment to health, wellness and inclusiveness. Learn more at usecu.org.

Mount Sinai Announces CastleVax Inc., a Clinical-Stage Infectious Diseases Company Developing Novel Vaccines and Therapeutics Targeting Pandemic Threats and Diseases


“Establishing CastleVax exemplifies our deep commitment to advancing our research, instruction, and public service missions,” said Erik Lium, PhD, President of Mount Sinai Innovation Partners and Chief Commercial Innovation Officer at Mount Sinai.

The Mount Sinai Health System in New York, NY, has launched CastleVax, Inc. (“CastleVax”), a clinical-stage vaccine research and development company. CastleVax is devoted to the commercial development of the Newcastle disease virus (NDV) vaccine platform technology originally developed in the laboratories of Peter Palese, PhD; Adolfo García-Sastre, PhD; and Florian Krammer, PhD, at the Icahn School of Medicine at Mount Sinai.

By efficiently engineering NDV to express stabilized antigenic proteins native to infectious viruses, such as the spike protein that SARS-CoV-2 uses to harpoon lung cells in humans and other animals, CastleVax is researching and developing vaccines against current and potential future pandemic threats, as well as diseases of profound unmet medical need. NDV is a member of the avian paramyxovirus family (APMV) and is widely considered to be well tolerated in humans.

Distinguishing features of this new vaccine platform technology:


  • The vaccine platform technology is based on Newcastle disease virus (NDV), a pathogen in the avian paramyxovirus family (APMV), that is harmless in humans. This platform has been engineered to facilitate creation of intranasal and intramuscular vaccines targeting emerging SARS-CoV-2 variants of concern, such as Omicron variants, in addition to a broad range of other viral pathogens.
  • The NDV platform enables formulation of live attenuated, intranasal vaccines and live attenuated and inactivated intramuscular vaccines, that can be stored at refrigeration temperatures without the need for specialized cold chain requirements.
  • CastleVax’s live attenuated, intranasal COVID-19 vaccine candidate, NDV-HXP-S, is currently being evaluated for its ability to induce mucosal immunity and stimulate IgA antibodies. Improved SARS-CoV-2 specific immune responses in the mucous membranes of the nose are viewed by infectious diseases experts as urgently needed to provide protection from breakthrough infection and to blunt transmission.
  • NDV-HXP-S expresses a stabilized version of the SARS-CoV-2 spike protein, called HexaPro, developed at The University of Texas at Austin in the laboratory of Dr. Jason McLellan, and is believed to exhibit an attractive safety profile with comparatively low reactogenicity in humans, as documented in ongoing clinical trials. Interim serological results from phase 1 and 2 clinical trials have demonstrated that NDV-HXP-S induces levels of neutralizing antibodies to the Wuhan strain of SARS-CoV-2 that are higher and/or equivalent to those of current Food and Drug Administration-approved vaccines.
  • NDV-HXP-S is based on an NDV strain that has not been observed to be immunogenic in humans. If immunogenicity to NDV-HXP-S or other NDV-vectored vaccines develops over time, the surface glycoproteins on the NDV-vectored vaccine can be replaced with substitute glycoproteins from other viruses in the APMV family, thereby addressing any such potential immunogenicity.
  • With a vaccine platform technology that has been successfully transferred to four independent manufacturers in low- and middle-income countries, existing manufacturers of influenza vaccines could potentially produce over a billion doses of NDV-vectored vaccines per year.

“This is an exciting moment for our platform,” said CastleVax President and CEO Matt Stober. “Over the last two years, our NDV-HXP-S vaccine technology has been transferred to clinical development partners in Brazil, Mexico, Vietnam, and Thailand, and they have already demonstrated the use of egg-based flu vaccine manufacturing processes. They’ve completed phase 1 and phase 2 clinical studies in vaccine-naïve adults, with evidence of acceptable safety and immunogenicity. We expect that our live virus intranasal booster study, being conducted at Mount Sinai, will report interim results during the fourth quarter of this year. The study is designed to demonstrate that our vaccine candidate can be used to prevent COVID-19 transmission and break-through infections. COVID-19 is the first step for our platform development. We aim to engineer vaccines to fight a broad range of future respiratory pandemic threats that experts in the field foresee as inevitable. The strength of our vaccine engineering platform allows us to advance our lead program, enter into global partnerships, and propel our other research and development opportunities.”

“Establishing CastleVax exemplifies our deep commitment to advancing our research, instruction, and public service missions,” said Erik Lium, PhD, President of Mount Sinai Innovation Partners and Chief Commercial Innovation Officer at Mount Sinai. “To achieve these missions, we focus on strategic research partnerships with industry, including startups that we form, to further develop and commercialize Mount Sinai inventions with potentially worldwide significance to healthcare.” Dr. Lium added, “The vaccine engineering technology we have licensed to CastleVax represents decades of seminal discoveries and inventions at Icahn Mount Sinai under the leadership of Drs. Palese, García-Sastre, and Krammer in applying recombinant genetic engineering to the study and creation of innovations in the fields of virology and immunology.”

Prior to establishing CastleVax, Mount Sinai worked with an international consortium to develop the intramuscular NDV-HXP-S vaccine against COVID-19. The consortium consists of manufacturers in Brazil, Thailand, and Vietnam; not-for-profit organization PATH; and The University of Texas at Austin (UT Austin), which developed the HexaPro technology, stabilizing mutations in the spike protein used in the vaccine. Mount Sinai and UT Austin’s non-exclusive licenses enabled these three government-related, low- and middle-income countries to develop NDV-HXP-S targeted at the ancestral Wuhan strain of SARS-CoV-2. Encouraged by the early-stage results achieved by all three of these programs, Mount Sinai has granted an exclusive license to CastleVax to extend the NDV platform to creating vaccines targeted at the emerging SARS-CoV-2 variants of concern, for which there is significant unmet need arising from growing transmission and breakthrough cases of COVID-19. As these variants of concern have emerged and surged in worldwide waves, the effectiveness of ancestral Wuhan strain-based vaccines has diminished.

Mount Sinai has engaged H.C. Wainwright & Co. as CastleVax’s financial and capital markets advisor to assist the company with raising the financing needed to achieve its goals.

The NDV-vectored vaccine platform is based on technology developed by Mount Sinai faculty and licensed to CastleVax. Mount Sinai and Mount Sinai faculty, specifically Drs. Palese, García-Sastre, Krammer, and Weina Sun, PhD, have a financial interest in CastleVax. Mount Sinai is represented on the CastleVax Board of Directors by Dr. Lium, Dennis Charney, MD, and Stephen Harvey, MBA.

About the NDV-vectored Vaccine Platform:

NDV is an avian paramyxovirus (APMV) pathogen, considered harmless to humans. Humans usually lack pre-existing immunity toward NDV, which makes the virus preferable over other viral vectors that are human pathogens, such as human adenovirus, measles virus or modified vaccinia Ankara (MVA). As a large negative strand RNA virus, NDV is stable and amenable to engineering antigenic proteins such as the SARS-CoV-2 spike protein into its genome. This allows for the construction of vaccines targeting a broad range of viral pathogens.

CastleVax’s lead candidate, NDV-HXP-S, can be formulated as a live or inactivated NDV-vectored vaccine. The live formula can be administered intranasally or intramuscularly, and the inactivated formula can be administered intramuscularly. The NDV-vectored vaccines express a stabilized SARS-CoV-2 spike protein, utilizing HexaPro technology developed in the laboratory of Dr. Jason McLellan at The University of Texas at Austin and licensed on a nonexclusive basis to CastleVax. Stabilizing the spike protein in its “prefusion” conformation —its structure before being converted into the form it takes to be able to fuse with lung and other cells —underlies the immunizing effect of NDV-HXP-S. The vaccine has an attractive safety profile and low reactogenicity in humans as documented in several completed and on-going phase 1 and phase 2 clinical trials (NCT04871737, NCT05205746, and NCT05181709). In addition, clinical development of an inactivated version of the NDV-HXP-S COVID-19 vaccine is underway with partners in Thailand (NCT04764422), Vietnam (NCT04830800), and Brazil (NCT04993209, NCT05354024). Of logistical and economic significance, NDV-HXP-S is stable for at least six months at 2-8 °C; followed by retained potency for 3 days at 40°C, thus solving the last mile issues in low- and middle-income countries (LMICs).

Aligned with the unmet clinical need to block the SARS-CoV-2 transmission chain and prevent breakthrough infections, the live NDV-HXP-S COVID-19 vaccine delivered intranasally is currently being evaluated for its ability to elicit robust mucosal immune responses. Importantly, there is growing consensus in the wider scientific community that a SARS-CoV-2-specific immune response at the portal of entry, i.e., the upper respiratory tract, is required to provide protection from breakthrough infection and transmission.

The NDV-vectored vaccine platform facilitates the manufacture of vaccines by enabling vaccines to grow to high titers in embryonated chicken eggs, using essentially the same process for production of influenza virus vaccines. This established and robust egg-based NDV manufacturing process has been successfully used by multiple LMIC manufacturers. In a time of urgent need for innovative vaccines, influenza vaccine manufacturers could potentially produce well over a billion doses of NDV-vectored vaccines per year and thus meet vaccine needs on a global scale. In addition, CastleVax has identified a cell-based platform with the potential to expand capacity even further.

About CastleVax Inc.

CastleVax Inc. is a leading vaccine platform company based on technology developed at the Icahn School Medicine at Mount Sinai, the medical school within the Mount Sinai Health System, headquartered in New York City. The CastleVax platform utilizes Newcastle Disease Virus (NDV) to induce the human immune system to produce neutralizing antibodies targeted at a ranged of emerging and pandemic viruses, such as SARS-CoV-2 and other infectious viruses that attack the human respiratory system and other vital organs. The technology was developed in response to the growing need for vaccine independence and pandemic response preparedness. CastleVax’s leading candidate, NDV-HXP-S, targeted against COVID-19, is currently being tested in clinical trials in multiple countries around the world, including the U.S., Thailand, Vietnam, Brazil, and Mexico. For more information visit, https://www.castlevax.com and follow CastleVax on Twitter and LinkedIn.

About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report’s Best Hospitals, receiving high “Honor Roll” status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children’s Hospital among the country’s best in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report’s “Best Medical Schools,” aligned with a U.S. News & World Report “Honor Roll” Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally. For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter, and YouTube.

About the Icahn School of Medicine at Mount Sinai

The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the eight member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to a large and diverse patient population.

Ranked 14th nationwide in National Institutes of Health (NIH) funding and among the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges, Icahn Mount Sinai has a talented, productive, and successful faculty. More than 3,000 full-time scientists, educators and clinicians work within and across 34 academic departments and 35 multidisciplinary institutes, a structure that facilitates tremendous collaboration and synergy. Our emphasis on translational research and therapeutics is evident in such diverse areas as genomics/big data, virology, neuroscience, cardiology, geriatrics, as well as gastrointestinal and liver diseases.

Icahn Mount Sinai offers highly competitive MD, PhD, and Master’s degree programs, with current enrollment of approximately 1,300 students. It has the largest graduate medical education program in the country, with more than 2,000 clinical residents and fellows training throughout the Health System. In addition, more than 550 postdoctoral research fellows are in training within the Health System.

The Icahn School of Medicine at Mount Sinai is located in New York City on the border between the Upper East Side and East Harlem and classroom teaching takes place on a campus facing Central Park. Icahn Mount Sinai’s location offers many opportunities to interact with and care for diverse communities. Learning extends well beyond the borders of our physical campus, to the eight hospitals of the Mount Sinai Health System, our academic affiliates, and globally.

——————————————————-

*Mount Sinai Health System Member Hospitals: The Mount Sinai Hospital; Mount Sinai Queens; Mount Sinai Beth Israel; Mount Sinai West (previously known as Mount Sinai Roosevelt); Mount Sinai Morningside (previously known as Mount Sinai St. Luke’s); Mount Sinai Brooklyn; New York Eye and Ear Infirmary of Mount Sinai; and Mount Sinai South Nassau (previously known as South Nassau Communities Hospital).

About Mount Sinai Innovation Partners

Mount Sinai Innovation Partners (MSIP) is responsible for driving the real-world application and commercialization of Mount Sinai discoveries and inventions, and the development of research partnerships with industry. Our aim is to translate discoveries and inventions into healthcare products and services that benefit patients and society. MSIP is accountable for the full spectrum of commercialization activities required to bring Mount Sinai inventions to life. These activities include evaluating, patenting, marketing, and licensing new technologies, building research collaborations and partnerships with commercial and nonprofit entities, material transfer and confidentiality, coaching innovators to advance commercially relevant translational discoveries, and actively fostering an ecosystem of entrepreneurship within the Mount Sinai research and health system communities. For more information, please visit https://ip.mountsinai.org/ or find MSIP on LinkedIn, Twitter, Facebook, Medium, and YouTube.

Vivos Announces 4th Annual Breathing Wellness Conference in Cancún, Mexico, with Full Slate of World-Renowned Speakers


The Breathing Wellness Conference is, hands down, my favorite conference of the year! The lecturers are always phenomenal, and the camaraderie of dental professionals is unparalleled.

Vivos Therapeutics, Inc. (NASDAQ: VVOS) (“Vivos”) is excited to announce the fourth annual Breathing Wellness Conference, which will take place Oct. 26–29, 2022, at the Hilton Hotel in Cancún, Mexico. The conference will be hosted by The Vivos Institute, the educational branch of Vivos Therapeutics.

Dentists, dental teams, and medical doctors from around the world gather at this annual conference to learn from top experts in the industry and explore the impact of obstructive sleep apnea (OSA) on overall health and chronic conditions, including heart disease, type 2 diabetes, dementia, and chronic fatigue. Participants also have the chance to explore the latest innovations in dental sleep medicine and how they can be implemented within their own practices to help their patients.

“Our annual Breathing Wellness Conference brings together leading clinicians and researchers from a wide range of healthcare disciplines and serves as a platform where we can learn about the causes and serious health consequences of OSA and the latest advances in the world of sleep medicine while continuing to spread the message about Vivos’ breakthrough technology,” said Kirk Huntsman, Chairman, and CEO of Vivos.

In years past, attendees have gained practice benefits and treatment options that can be life-altering for OSA patients. “The Breathing Wellness Conference is, hands down, my favorite conference of the year! The lecturers are always phenomenal, and the camaraderie of dental professionals is unparalleled,” said Dr. Michelle Rowe, a Vivos Integrated Provider, and owner and general dentist of Willow Spring Family Dentistry in Centennial, Colorado. “I have met some of my closest friends and some of the most inspirational dentists at this conference. I highly recommend this conference for all doctors who are starting their journey into sleep dentistry.”

“I invested to bring 12 team members across the country for the Vivos Breathing Wellness Conference last year,” said Dr. James Massa, owner of Massa Dental Center in Naples, Florida, and a Vivos Integrated Provider. “It was one of the best investments of my 30-year dental career! Thanks to this conference, our team is knowledgeable, motivated, and invested in life-changing therapy that improves our patients’ and families’ lives everyday.”

This year, attendees will have the opportunity to hear from the following guest speakers:

For more information about the Breathing Wellness Conference, including registration, please visit thevivosinstitute.com/bwc22.

About Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. (NASDAQ: VVOS) is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (OSA) and snoring in adults. The Vivos Method represents the first clinically effective nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution. It has proven effective in over 28,000 patients treated worldwide by more than 1,600 trained dentists.

The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and associated protocols that alter the size, shape and position of the tissues that comprise a patient’s upper airway. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild-to-moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (VIP) program offers dentists training and other value-added services in connection with using The Vivos Method.

Cautionary Note Regarding Forward-Looking Statements

This press release and statements of the Company’s management and third parties made in connection therewith contain “forward-looking statements” (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) concerning future events, particularly with respect to the public offering described herein. Words such as “aim,” “may,” “could,” “expects,” “projects,” “intends,” “plans,” “believes,” “predicts,” “anticipates,” “hopes,” “estimates” and variations of such words and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks and are based upon several assumptions and estimates, which are inherently subject to significant uncertainties and contingencies, many of which are beyond Vivos’ control. Actual results (including, without limitation, the anticipated benefits of the 2022 Breathing Wellness Conference) may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, the risk factors described in Vivos’ filings with the Securities and Exchange Commission (“SEC”). Vivos’ filings can be obtained free of charge on the SEC’s website at http://www.sec.gov. Except to the extent required by law, Vivos expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Vivos’ expectations with respect thereto or any change in events, conditions, or circumstances on which any statement is based.

Share article on social media or email:

Marsala Law Group Launches Lifelong Hobby Scholarship for College Students


Marsala Law Group Launches Lifelong Hobby Scholarship

Marsala Law Group will be furthering its efforts to serve the Denton area community by offering the Lifelong Hobby Scholarship. Each semester beginning in Fall of 2022, the firm will provide a $1,000 scholarship to a deserving student. To apply, students must submit a 3-minute video discussing a hobby they consider to be a lifelong passion and explaining how they will continue to enjoy their hobby while pursuing education and later, working.

Attorney Dominick Marsala chose this topic because he believes that students and professionals alike can benefit from pursuing a hobby despite a hectic school or work schedule. Marsala Law Group values maintaining a healthy work-life–or school-life–balance, believing that a personal pursuit can help a person in other areas of their life.

The topic selected reflects the values of Marsala Law Group in encouraging young people to pursue healthy hobbies while seeking higher education, and throughout their lives. The firm welcomes this opportunity to give back to the community.

Applications will be judged based on the creativity, originality, and quality of the submission video, in addition to how well it addresses the prompt.

Student applicants must be enrolled in a graduate or undergraduate college program and must have a 3.0 GPA. To view other requirements and apply, students can visit: https://www.marsalalawgroup.com/scholarship

About Marsala Law Group

Marsala Law Group is a criminal defense law firm based in Denton, Texas. The firm takes on some of the most challenging criminal cases and takes great pride in providing clients with honest, aggressive representation. It represents clients accused of serious crimes such as sex offenses and violent crimes, as well as misdemeanors like DWI and domestic violence.

Marsala Law Group also offers family law and personal injury representation.

To learn more about Marsala Law Group, please visit: https://www.marsalalawgroup.com/. To schedule a consultation, please call 940-382-1976.

Share article on social media or email:

Actress Tina Lifford Wraps 7th and Final Season of Queen Sugar and Launches Wellness Program


Tina Lifford Launches SELF365

Tina Lifford Launches SELF365

“The quality of one’s interior life is directly related to the nature of their thoughts, feelings, and beliefs and how they respond to life circumstances. We can train ourselves to think, feel, and respond to life better like we train and strengthen our physical bodies.” Tina Lifford

Tina Lifford, author, trainer, and award-winning actress, who has starred on the OWN Network’s Queen Sugar throughout the seven-season run of the critically acclaimed series, is dedicating the next phase of her life to global wellbeing through personal inner fitness. As Founder and CEO of The Inner Fitness Project, Lifford defines “inner fitness” as strengthening the ability to reconnect to a more mentally, emotionally, and spiritually whole version of Self.

In October 2022, Lifford will launch the SELF365 program, which encourages participants to quickly shift to an empowering growth-producing perspective and sense of what is possible for their life during emotional overwhelm and triggers. Lifford advocates that interrupting limiting beliefs and behavior in support of personal wellbeing is a skill that can be learned and practiced.

It is predicted that by 2030, depression will be one of the most significant health risks on earth. The Inner Fitness Project aims to prioritize inner fitness and turn well-being concepts into lifestyle choices.

SELF365 is a 14-week online group experience guided by Lifford. Groups are comprised of five to seven participants. The program meets each participant where they are in a tailor-made way.

During the pandemic, Lifford saw a need for a community focused on inner health and wellbeing practices. “The quality of one’s interior life is directly related to the nature of their thoughts, feelings, and beliefs and how they respond to life circumstances. We can train ourselves to think, feel, and respond to life better like we train and strengthen our physical bodies,” she says.

By taking simple, practical actions learned in the SELF365 program, participants will…


  • Develop the ability to shift perspective and make a self-empowering response in any situation
  • Achieve a greater sense of Self
  • Relish in a safe space to process emotions and grow
  • See and transform limiting beliefs and patterns
  • Recognize new possibilities in every area of life
  • Discover they are not alone in their struggles
  • Practice. Practice. Practice.

Participants of SELF365 have reported higher levels of internal calm, increased life satisfaction, better communication skills, and greater emotional, mental, and spiritual freedom. Now more than ever, the world needs supportive, uplifting, and dependable systems to deal with changing environments. SELF365 provides this support and is ideal for anyone seeking a breakthrough towards achieving external success and inner happiness in their life in new and powerful ways.

For more information on the program, go to http://www.theinnerfitnessproject.com.

About The Inner Fitness Project and Tina Lifford

Tina Lifford founded The Inner Fitness Project in 2011 after decades of involvement in the Wellness space and graduating from a two-year intensive Spiritual Psychology program in 2005.

Over recent years, Tina has leveraged her global platform to bring attention to proactive ways to strengthen internal wellbeing. Her book, “The Little Book of Big Lies,” published by Amistad, a HarperCollins imprint, put actionable tools in readers’ hands, and Forbes.com named it a must-read for 2021. Tina and The Inner Fitness Project are committed to teaching effective, reliable “inner” practices for navigating the past, present, and future with resilience, power, and vision.

Share article on social media or email: